Advertisement
Drug Therapy
Drug Therapy
09/01/2017
The US Food and Drug Administration has approved a new treatment option for adult and pediatric patients with CD33-positive acute myeloid leukemia.
09/01/2017
Leukemia
Leukemia
08/03/2017
After its efficacy was demonstrated in a clinical trial, the US Food and Drug Administration approved a new treatment options for adult patients with 2 types of poor-prognosis acute myeloid leukemia.
08/03/2017
Leukemia
Leukemia
08/01/2017
The US Food and Drug Administration recently approved a new treatment option for patients with relapsed or refractory acute myeloid leukemia who have IDH2 mutations.
08/01/2017